• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Dali Medical Devices completes first implementation of SAN-Light passive safety needle

January 12, 2022 By Sean Whooley

DALI Medical Devices SAN-Light Needle
[Image from Dali]
Dali Medical Devices announced today that it completed the first commercial implementation of the SAN-Light passive safety needle.

Tel Aviv, Israel-based Dali designed the SAN-Light single-use, sterile, hypodermic safety needle for compatibility with any Luer-lock syringe for subcutaneous or intramuscular drug administration.

SAN-Light makes up part of Dali’s SAN (safe auto needle) family of safety injectable drug delivery devices. All of the devices within the SAN family enable a more safe and easy-to-use injecting experience across a range of formulations, according to a news release.

Dali said the SAN-Light system includes an automatically-activated (passive) needle shield to reduce needlestick injuries, while the partially hidden needle alleviates needle anxiety.

SAN-Light was chosen for use with Advanz Pharma’s Mytolac/Myrelez, the first generic lanreotide drug product for treating acromegaly and gastroenteropancreatic neuroendocrine tumors. The product incorporates a prefilled syringe and a special version of the SAN-Light needle customized to fit the drug parameters and users’ needs.

“We are delighted to have worked with Advanz Pharma on this important, unique solution,” Dali CEO David Daily said in the release. “It’s a win-win collaboration that helps patients and enhances the commercialization of Advanz Pharma’s drug product by enabling a better experience and ease of administration.”

Filed Under: Auto-injectors, Business/Financial News, Drug-Device Combinations, Featured, Pharmaceuticals Tagged With: Advanz Pharma, Dali Medical Devices

IN CASE YOU MISSED IT

  • Tandem Diabetes Care wins CE mark for Mobi insulin pump with Control-IQ+ technology
  • Glooko adds chief strategy officer to chief medical officer’s title
  • Cordis launches 10,000-patient registry for drug-eluting balloon
  • Senseonics opens $50M public offering, $25M private placement with Abbott
  • Study links Abbott CGM use to lower risk of hospitalizations due to heart complications

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS